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Abstract: Postoperative bacterial infections are common despite prophylactic administration 
of  antibiotics.  The  wide-spread  use  of  antibiotics  in  patients  has  contributed  to  the 
emergence of multiresistant bacteria. A restricted use of antibiotics must be followed in 
most  clinical  situations.  In  surgical  patients  there  are  several  reasons  for  an  altered 
microbial flora in the gut in combination with an altered barrier function leading to an 
enhanced inflammatory response to surgery. Several experimental and clinical studies have 
shown  that  probiotics  (mainly  lactobacilli)  may  reduce  the  number  of  potentially 
pathogenia bacteria (PPM) and restore a deranged barrier function. It is therefore of interest 
to test if these abilities of probiotics can be utilized in preoperative prophylaxis. These 
factors  may  be  corrected  by  perioperative  administration  of  probiotics  in  addition  to 
antibiotics. Fourteen randomized clinical trials have been presented in which the effect of 
such regimens has been tested. It seems that in patients undergoing liver transplantation or 
elective surgery in the upper gastrointestinal tract prophylactic administration of different 
probiotic strains in combination with different fibers results in a three-fold reduction in 
postoperative  infections.  In  parallel  there  seems  to  be  a  reduction  in  postoperative 
inflammation, although that has not been studied in a systematic way. The use of similar 
concepts in colorectal surgery has not been successful in reducing postoperative infections. 
Reasons for this difference are not obvious. It may be that higher doses of probiotics with 
longer duration are needed to influence microbiota in the lower gastrointestinal tract or that 
immune function in colorectal patients may not be as important as in transplantation or 
surgery in the upper gastrointestinal tract. The favorable results for the use of prophylactic 
probiotics  in  some  settings  warrant  further  controlled  studies  to  elucidate  potential 
mechanisms, impact on gut microbiota and influence on clinical management. The use of 
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probiotics  must  be  better  delineated  in  relation  to  type  of  bacteria,  dose  and  length 
of administration. 
Keywords: probiotics; postoperative infections; immune function; bacterial translocation; 
gastrointestinal surgery; liver transplantation 
 
1. Introduction 
Bacterial  infection  is  a  frequent  complication  following  operations  in  the  gastrointestinal  tract. 
Despite prophylactic administration of antibiotics the incidence of postoperative infections ranges from 
10–30% in resectional surgery [1]. Most infections are caused by bacteria of enteric origin 2. In spite 
of  restricted  use  of  prophylactic  antibiotics,  the  emergence  of  antibiotic  resistance  has  increased 
significantly 3. The gut microbial flora and mucosa are also affected by surgical trauma resulting in 
the gut barrier dysfunction and intestinal microbial imbalance. This may further aggravate systemic 
inflammation and depress immune function 4. All these factors contribute to an increased risk of 
postoperative  infections  and  sepsis.  Alternative  strategies  in  preparing  patients  for  gastrointestinal 
surgery besides mechanical bowel preparation and administration of antibiotics must be considered. 
Probiotics (live microorganisms which, when consumed in adequate amounts as part of food, confer 
a health benefit on the host) are able to influence several of these factors. They can stabilize the 
intestinal barrier by stimulating epithelial growth, mucus secretion and motility as well as enhance 
innate immunity by inhibition of IL-10 and stimulation of secretory IgA, neutrophils and reduction  
of  inflammatory  cytokines  5.  The  effects  on  IL-10  can  be  varied  with  both  inhibition  and  
stimulation.  Furthermore,  administration  of  probiotics  suppresses  growth  of  potentially  pathogenic 
microorganisms, e.g., E. coli and Enterobacteriaceae. It has been hypothesized by several authors that 
these characteristics can be used in a clinical setting of preoperative prophylaxis for reduction of 
postoperative  infections.  Preoperative  antibiotic  prophylaxis  constitutes  more  than  ten  percent  of 
antibiotic  usage  in  surgery  and  a  reduction  could  lead  to  a  reduced  pressure  on  development  of 
antibiotic  resistance.  It  may  therefore  be  of  interest  to  study  if  probiotics  may  be  used  in  the 
preoperative preparation of patients undergoing gastrointestinal operations. 
In  recent  years  a  few  randomized  trials  on  the  use  of  prophylactic  probiotics  in  major 
gastrointestinal surgery mostly for cancer and liver transplantation. Since this is a new concept on the 
use of probiotics, it is important to critically analyze these studies before a wider application. 
2. Upper Gastrointestinal Surgery (Table 1) 
Two  studies  from  Berlin  addressed  patients  undergoing  major  resections  in  the  upper 
gastrointestinal tract. In one study administration of Lactobacillus plantarum 299 (10
9) was compared 
to placebo and heat-killed bacteria 6. Bacteria were administered enterally 5–7 days before operation. 
The two groups receiving lactobacilli (live or heat-killed) had a postoperative infection rate of 10% 
compared to 30% in controls. This difference was statistically significant (p < 0.01). The influence on 
gut microbiote from administration of probiotics was not evaluated. The impact on immune parameters Nutrients 2011, 3  
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could not be shown since most parameters (NK cells, T cells and lymphocytes) were within normal 
limits in both study groups. 
In the other study, 89 patients undergoing pancreatic resections were included [7]. Patients were 
randomized to receive synbiotics or placebo starting one day before surgery and continued eight days 
postoperatively  7.  The  synbiotics contained four different lactic acid bacteria and four bioactive 
fibers: betaglucan, inulin, pectin and resistant starch. In total, 20 g of fiber per day was administered. 
There  was  a  significant  reduction  in  postoperative  surgical  site  infections  from  40%  to  12.5% 
(p < 0.05). There was also a shorter hospital stay in the synbiotic group and duration of antibiotic 
administration was shorter (median 2 vs. 10 days). Gut microbiota or effect on immune parameters was 
not studied. The total dose of bacteria was higher than the previous study 6 and the effect was related 
to live bacteria, since there was no use of heat-killed bacteria. The authors used a mixture of bacteria 
and fiber and the observed effect could also partly be ascribed to the fiber content. 
In another randomized controlled trial postoperative enteral administration of a synbiotic mixture of 
10
10 Lactobacillus casei and Bifidobacterium breve and 15 g/day of fiber (galactooligosaccharides) 
was studied [8]. One group received synbiotic treatment before and after operation, while one group 
only  had  postoperative treatment. Both groups  received antibiotic prophylaxis. When  therapy was 
given both pre- and postperatively there was a significant reduction in postoperative infection rate  
(12 vs. 30%). There was no difference in intestinal permeability measured by Lactulose-Mannitol test. 
The probiotic bacteria could be identified in feces upon administration. The pre- and postoperative 
administration resulted in an increase in NK cell activity, number of lymphocytes and IL-6, whereas 
CRP (C-reactive protein) decreased. The results are impressive, but the study is difficult to evaluate, 
since there is no proper control 8. 
Table  1.  Results  of  studies  on  the  use  of  probiotics/synbiotics  as  prophylaxis  for 
postoperative infections in elective surgery. 
Author  Patients  Comparison  Bacteria, type, 
doses 
Length of 
admin. 
SSI  Impact on 
flora 
Immuno-
modulation 
Rayes  
2002 [6] 
Abdom. 
surgery  
n = 90 
Live LB,  
heat-killed Lb 
vs. 
placebo 
Lb plantarum 299 
10
9 
5–7 days  30% 
vs. 
10% 
vs. 
10% 
Not studied  No diff. 
Rayes  
2007 [7] 
Pancreo-
duodenectomy 
n = 89 
Synbiotics 
vs. 
placebo 
Pediococcus pent 
Leuconsultic mes 
Lb paracasei 
Lb plantarum 
10
10 
9 days  12.50% 
vs. 
40% 
Not studied  Not studied 
Sugawara 
2006 [8] 
Biliary surgery 
n = 81 
Synbiotics postop 
vs. 
synbiotics 
pre/postop 
Lb casel 
B. breve 
10
10 
2 w before 
vs. 
2 w after op 
30% 
vs. 
12.10% 
Lb 
increased 
IL-6, WBC 
increased 
CRP 
decreased Nutrients 2011, 3  
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Table 1. Cont. 
McNaught 
2002 [9] 
Abdom. 
surgery 
mostly colon 
resection 
n = 129 
Lb 
vs. 
placebo 
Lb plantarum 
299v 
5 ×  10
7 
1 w before 
op + postop 
13% 
vs. 
15% 
Lower 
PPM 
Translocation 
and CRP 
unchanged 
Anderson 
2004 [10] 
Abdom. 
surgery  
n = 137 
Synbiotics 
vs. 
placebo 
Lb bulgaricus 
Lb acidophilus 
B. lactis 
Streptoccus therm 
4 ×  10
9 
12 days  32% 
vs. 
31% 
Not studied  No diff. in 
bact. 
translocation 
CRP, IL-6  
and Ig M 
Reddy 
2006 [11] 
Colonic 
surgery 
n = 88 
Placebo 
vs. 
Neomycin 
vs. 
Synbiotics + MBP 
vs. 
Synbiotics − MBP 
Lb bulgaricus 
Lb acidophilus 
B. lactis 
Streptoccus therm 
4 ×  10
9 
 
?  No diff. 
between 
groups 
17% 
overall 
Synbiotics + 
MBP 
reduced 
Entero- 
bacteriacease 
Synbiotics 
MBP 
reduced bact. 
translocation 
Hovart 
2010 [12] 
Colon 
Surgery 
n = 68 
Synbiotics 
vs. 
heat killed bact. 
vs. 
placebo 
Pedioccus pent. 
Leuconostic mesent 
Lb paracasei 
2362 
10
12 
3 days preop No diff. 
between 
groups 
Not studied  Higher IL-6 
and fibrinogen 
postop in 
synbiotic 
group 
Rayes 
2000 [13] 
Liver 
transplant. 
n = 95 
Selective bowel 
decontamination 
vs. 
Lb 
vs. 
placebo 
Lb plantarum 299 
10
9 
12 days  48% 
vs. 
13% 
vs. 
34% 
Not studied  WBC decrease 
Rayes 
2004 [14] 
Liver 
transplant. 
n = 66 
Synbiotics 
vs. 
placebo 
Pediacoccus pent 
Leuconsultic mes. 
Lb paracasei 
Lb plantarum 
10
10 
15 days  3% 
vs. 
48% 
Not studied  No diff. 
Eguch 
2010 [15] 
Living donor 
Liver 
transplant. 
n = 50 
Synbiotics 
vs. 
placebo 
Lb casei 
B. breve 
14 days  4% 
vs. 
24% 
No diff.  Not studied 
Woodard 
2009 [16] 
Gastric 
by pass 
n = 41 
Probiotics 
vs. 
control 
Lb species 
10
8 
6 months  Not 
studied 
Probiotics 
reduced 
bacterial 
over-growth 
Not studied 
Lb: Lactobacilli; B.: Bifidobacteria; SSI: Surgical site infection. Nutrients 2011, 3  
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3. Lower Gastrointestinal Surgery (Table 1) 
An early study comparing administration of Lactobacillus plantarum 299v pre- and postoperatively 
with placebo did not show any significant difference in postoperative infections 9. Translocation and 
CRP levels were unchanged in the two groups. There was a reduction in the number of potentially 
pathogenic microbes. The amount of lactobacilli administered was, however, rather low (5 ×  10
7), 
which partly explains the absence of effect on postoperative infections. The study population consisted 
of both upper and low gastrointestinal urgery, but mostly colorectal resections (82/129). They were not 
analyzed separately, but the overall postoperative sepsis rate was 13% and 15% for treatment and 
controls. These figures are well in line with what could be expected in such a study population.  
In another study from the same group, a synbiotic mixture containing four bacteria and fiber was 
compared to placebo 8. The administration was started two weeks prior to colonic surgery. The dose 
was higher than in the previous study 9 (4 ×  10
9), but there was still no effect on postoperative sepsis, 
bacterial translocation or inflammatory markers 10. Surprisingly, there was a three-fold increase in 
postoperative infections in this study compared to the other from the same group with the same type 
of surgery. 
The same research group has made yet another contribution to the field [11]. They randomized 
88 patients undergoing colectomy to four groups with 20–24 patients in each group: mechanical bowel 
preparation alone; with added neomycin; addition of synbiotics; and synbiotics and neomycin but no 
bowel preparation. The amount of bacteria was 4 ×  10
9. It is not clearly stated how long the symbiotic 
mixture  was  administered. Bacterial  translocation  was determined by culture of  mesenteric lymph 
nodes and intestinal permeability measured by triple sugar test.  
There were no significant alterations of bacterial translocation or intestinal permeability, although 
bacterial translocation seemed lower in patients with mechanical bowel preparation, neomycin and 
synbiotics.  Similarly,  in  patients  who  had  all  three  interventions  a  significant  reduction  in 
Enterobacteriaceae in the colon was observed. These findings did not appear to have any effect on the 
incidence of postoperative infections and the septic rate is 17% overall with no difference between the 
groups. This well-performed study is unfortunately limited by the low number of patients. The study 
was only powered to study impact on translocation. 
A newly presented study compared synbiotics, prebiotic with heat-killed bacteria and placebo in 
patients  planned  for  colonic  resection  [12].  The  same  bacterial  composition  was  used  as  in  the 
two studies referenced as 9 and 10, but a significantly higher amount of bacteria was administered. 
The study products were given only for three days preoperatively and there seems to be no influence 
on postoperative wound sepsis, although very little information is given in the paper 12. It seemed 
that the postoperative inflammatory response was higher in the synbiotic group, but the reasons for this 
is not obvious from the study [12]. The paucity of data and the very short length of administration 
make the contribution of this study to the field of preoperative use of probiotics very limited.  
4. Liver Transplantation (Table 1) 
One of the earliest presented studies on preoperative use of probiotics was performed in patients 
undergoing liver transplantation. The transplantation team in Berlin randomized patients undergoing Nutrients 2011, 3  
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liver transplantation to either selective bowel decontamination, administration of living lactobacilli 
during  12  days,  or  placebo  containing  heat-killed  lactobacilli  [13].  The  probiotic  used  was 
Lactobacillus plantarum 299 in a reasonable high dose. All patients received prophylactic antibiotics 
according  to  local  routines.  There  was  a  significant  reduction  in  postoperative  sepsis  and  wound 
infection rate in the group that received living probiotics: 13% vs. 34% and 48% with heat-killed 
lactobacilli and bowel decontamination, respectively. Most infections were cholangitis and pneumonia 
and the most commonly isolated bacteria was enterococci. They also observed a shorter hospital stay, 
lower number of days in intensive care and a decreased use of additional antibiotics in the group that 
received  supplementation  of  lactobacilli  13.  Postoperative  leukocyte  count  was  lower  in  the 
lactobacilli group. The results of this study are impressive but mechanisms underlying the observed 
effects could not be clarified. No evaluation of intestinal mucosal floras was done. 
The same research group presented another study on liver transplantation patients [14]. In this 
study, patients were randomized to receive either synbiotics in high amounts, administered during 
15 days, or placebo without bacteria. The postoperative infection rate was 3% and 48% respectively, 
which  is  highly  significant and  in  line with the previous  study. Additional use of antibiotics  was 
similarly reduced. No cultures of intestinal content were done. The reason for the striking reduction in 
postoperative  infections  is  not clear.  There did  not seem  to be  any influence  on cellular  immune 
parameters in any group.  
A  newly  published  study  addressed  similar  questions  in  patients  undergoing  living  donor  liver 
transplantation  [15].  In  these  patients  postoperative  infectious  complications  are  as  frequent  as  in 
patients  undergoing  whole  liver  transplantation.  All  patients  received  a  synbiotic  mixture  starting  
two days before transplantation and continued two weeks following transplantation. A commercially 
available  mixture  was  used  containing  Lactobacillus  casei  and  Bifidobacterium  breve.  Controls 
received placebo. Postoperative sepsis was significantly reduced from 24% to 4%. Most infections 
were caused by Enterococcus spp. and methicillin-resistant Staphylococcus aureus. Bacterial profiles 
in fecal cultures were normalized post-transplant in the synbiotic group compared to controls.  
Immune parameters were not analyzed [15]. 
The results of this study are in line with the other two studies and support the use of probiotics in 
future studies in these patients. 
5. Bariatric Surgery (Table 1) 
In patients undergoing gastric by pass surgery for morbid obesity, there is a risk that the enteric 
microflora may be altered resulting in bacterial overgrowth in the small bowel [17]. This results in 
nausea, flatulence, diarrhea and abdominal pain. Long-term administration of antibiotics does not seem 
reasonable to avoid these problems. Another solution could be the use of probiotics. In one recent 
study, 44 patients undergoing gastric by-pass surgery were randomized to probiotics or placebo [16]. 
Patients in the probiotic group were given a six month supplement of a commercially available mixture 
of Lactobacillus species. Bacterial overgrowth was evaluated by hydrogen breath test.  
The probiotic group demonstrated significantly fewer signs of bacterial overgrowth than the control 
group [16]. The breath test was performed at several time points during the study and the effect on 
bacterial  overgrowth  was  checked  after  three  months  on  probiotics.  Unfortunately  no  cultures  of Nutrients 2011, 3  
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aspirate from the intestines were done so a qualitative evaluation of floral changes could not be carried 
out, and the effects of the breath test could be related to other factors than administration of live bacteria. 
The indication for use of probiotics in patients with gastric by-pass is further supported by a recent 
experimental study reporting a relationship between microflora and energy expenditure [18]. Therefore 
probiotics may safely improve gastrointestinal symptoms after by gastric by-pass surgery including a 
potential weight loss. 
6. Discussion 
There seems to be striking differences in effects of prophylactic administration of probiotics in 
different surgical patients. The results relating to reduction in postoperative infections are convincing 
when used in patients undergoing surgery in the upper gastrointestinal tract and liver transplantation. 
The use in patients undergoing colorectal surgery does not seem to show any benefit. It is difficult to 
compare studies performed in different patient groups, since the design of studies is very different both 
in  relation  to  type  of  bacteria/fiber,  dose  and  length  of  administration.  Since  the  results  of  many 
controlled trials point in the same direction, one can speculate that the conditions for this therapy are 
very different in specific parts of the gastrointestinal tract. The small bowel and liver harbor a large 
part of the immune system and maybe the effect of immune modulation play a greater role in surgery 
in liver, pancreas and biliary tract as well as oesophagus and stomach. The bacterial content in these 
organs is relatively low or absent and therefore it may be easier to influence the microbial balance by 
administration of probiotics and fiber.  
The conditions for use of probiotics in colon and rectum may, on the other hand, be different. In 
these organs the immune cells play a less prominent role and the number of mucosa-associated bacteria 
is far greater. This infers that immune modulation probably plays a minor role in colorectal surgery 
and that it is more important to have an impact on the microbiota. Thus, much higher doses and longer 
duration of administration of probiotics may be required to detect such an effect. 
Although  clinical  results  related  to  reduction  of  infections  are  evident  in  several  studies,  few 
attempts  have  been  made  to  elucidate  potential  mechanisms.  There  are  some  indications  that  the 
inflammatory response to surgery is reduced [8,13]. Potential reduction of bacterial translocation was 
studied in a few reports and results are inconsistent [9–11] and effect is minor, if present at all. The 
major  problems  with  all  these  studies  are  the  lack  of  proper  evaluation  of  mucosal  microbiota. 
Although most authors claim the potential effect of probiotics on gut microbiota, the absence of proper 
analysis makes it difficult to evaluate the clinical use of probiotics as prophylaxis of postoperative 
infections. The administered probiotics could be retrieved in one study [8] and reduction of potentially 
pathogenia bacteria (PPM) as a result of bacterial antagonism was observed in some studies [9,10,18]. 
The relation of these results to reduction of postoperative infections has not been analyzed. Future 
studies in this field must more clearly address these issues. The length of administration, dose and type 
of probiotics used must be clarified, as well as how impact of probiotics on gut microbiota can be 
evaluated in patients. Furthermore, most studies imply that observed effects relate to the action of live 
bacteria,  although  heat-killed  bacteria  may  infer  effects  as  well.  This  has  been  addressed  in  only 
two studies  [6,12],  where  heat-killed  bacteria  did  not  seem  to  have  an  impact  on  postoperative 
infections. Most authors in the cited studies infer direct effects by live probiotics on gut microbiota as Nutrients 2011, 3  
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possible mechanism of action, but since the contribution of altered microflora and immune function to 
postoperative infections is not clear, the issue on live vs. heat-killed bacteria must be the focus in 
future studies. 
Administration of probiotics is in general considered safe and many of them are used in different 
products commercially available to the public. They have been used for many years and reports of side 
effects have been very few. However, when live bacterial are administered to patients, safety must be 
carefully  monitored.  Patients  with  depression  of  immune  function  may  be  more  susceptible  to 
complications than healthy individuals. Although few reports on sepsis induced by administration of 
probiotics exist, this possibility must be carefully monitored. Furthermore, recent reports indicating 
increased morbidity and mortality when used in patients with severe pancreatitis also highlight safety 
concerns. These groups of patients with an ongoing severe inflammation are probably different from 
patients  undergoing  elective  operations.  The  results  of  controlled  trials  performed  so  far  indicate 
therapy with probiotics seems safe and without any reported serious side-effects. Further studies are 
warranted to elucidate potential mechanisms of action in order to optimize its use.  
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